Skip to primary navigation
Skip to content
Clinical Trial: Embarca Clinical Trial, National Breast Cancer Coalition is promoting. It's for BMN 673, a PARP Inhibitor for Advanced and/or Metastatic Breast Cancer Patients with a BRCA Mutation
Go to URL
Added 19 Aug 2014
There are currently no comments on this link.